Novartis Pharma B.V.

Location

Noord-Holland

Founded

1948-02-10

Risk Signals

21161 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Novartis Pharma B.V.

Live alerts from global media, monitored by Business Radar

Civil war over parallel exports: "40 drugs are unnecessarily banned", say Pharmacists

2024-01-25 (newsit.gr)

Civil war over parallel exports: "40 drugs are unnecessarily banned", say Pharmacists

The lifting of the export ban on 137 medicines by the EOF has led to a "war" with many reactions. From the moment that the National

Read more
Pharma Online - Richter introduces three products to the Russian market

2023-11-03 (pharmaonline.hu)

Pharma Online - Richter introduces three products to the Russian market

Richter is expanding its range in Russia with medicines suitable for the treatment of diabetes, Világgazdaság reports.

Read more
Netanyahu “We are preparing for the ground invasion of Gaza”

2023-10-25 (corrierepl.it)

Netanyahu “We are preparing for the ground invasion of Gaza”

TEL AVIV (ISRAEL) (ITALPRESS) – “We are preparing for a ground invasion in Gaza. I cannot give further details at the moment, the timing will be decided based on consensus." Israeli Prime Minister Benjamin Netanyahu said this in a message to the nation.

Read more
The war in the Middle East shakes up the Swiss economy

2023-10-23 (20min.ch)

The war in the Middle East shakes up the Swiss economy

The war in the Middle East is putting many Swiss companies present in Israel in a bind.

Read more
Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

2023-10-17 (zofingertagblatt.ch)

Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

Israel: This is how Roche, Novartis and Lonza react to the war

Read more
Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

2023-10-17 (zofingertagblatt.ch)

Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

Israel: This is how Roche, Novartis and Lonza react to the war

Read more
Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

2023-10-17 (zofingertagblatt.ch)

Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

Israel: This is how Roche, Novartis and Lonza react to the war

Read more
Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

2023-10-17 (zofingertagblatt.ch)

Roche, Novartis and Lonza have branches in Israel - this is how they react to the war - Zofinger Tagblatt

Israel: This is how Roche, Novartis and Lonza react to the war

Read more
Swiss-based firms active in Russia are ‘filling Putin’s war chest’

2023-07-09 (swissinfo.ch)

Swiss-based firms active in Russia are ‘filling Putin’s war chest’

Swiss companies that continue to do business and pay millions in taxes in Russia are helping to fund Moscow’s war in Ukraine, activists say.

Read more
The pharmaceutical industry is sticking to exports to Russia

2023-02-16 (badische-zeitung.de)

The pharmaceutical industry is sticking to exports to Russia

Despite the sanctions against Russia, the German pharmaceutical industry increased its exports to the Putin empire in 2022. The Basel pharmaceutical giants Novartis and Roche also continue to deliver.

Read more
Novartis and Teva announce expansion plans in Russia

2012-07-05 (thepharmaletter.com)

Novartis and Teva announce expansion plans in Russia

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest pharmaceutical and biotechnology producers, to establi

Read more
Novartis and Teva announce expansion plans in Russia

2012-07-05 (thepharmaletter.com)

Novartis and Teva announce expansion plans in Russia

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest pharmaceutical and biotechnology producers, to establi

Read more

Never miss a headline about Novartis Pharma B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages